Winkler, Jeremy W.
Orr, Sarah K.
Dalli, Jesmond
Cheng, Chien-Yee C.
Sanger, Julia M.
Chiang, Nan
Petasis, Nicos A.
Serhan, Charles N.
Article History
Received: 24 September 2015
Accepted: 1 December 2015
First Online: 8 January 2016
Competing interests
: CNS is an inventor on patents [resolvins] assigned to BWH and licensed to Resolvyx Pharmaceuticals. CNS is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. CNS’ interests were reviewed and are managed by the Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. NAP is an inventor on patents assigned to the University of Southern California licensed for clinical development and retains stock in Resolvyx Pharmaceuticals.